Inhibrx Biosciences, Inc. Common Stock

INBXNASDAQ • USD
88.61 USD
↘ 4.77 (5.11%)AT CLOSE (03:59 PM EDT)
88.57
↘ 0.04 (0.05%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
88.57
↘ 0.04 (0.05%)
🔴Market: CLOSED

INBX is currently priced at $88.38. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (260.8%) and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Oct 26, 2026.

Open?$93.80
High?$94.46
Low?$86.92
Prev. Close?$93.38
Volume?251.2K
Avg. Volume?240.0K
VWAP?$89.66
Rel. Volume?1.05x
Bid / Ask
Bid?$67.08 × 100
Ask?$100.83 × 100
Spread?$33.75
Midpoint?$83.96
Valuation & Ratios
Market Cap?1.4B
Shares Out?14.7M
Float?9.6M
Float %?65.5%
P/E Ratio?N/A
P/B Ratio?-25.94
EPS?-$9.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
1.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
23
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.74Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?35.46%Squeeze Risk
Short Interest?3.4M
Days to Cover?16.8
Free Float9.6M
Avg Daily Volume203.0K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.07Strong
Quick Ratio?5.07Strong
Cash Ratio?4.75Strong
Debt/Equity?-3.33Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-25.94CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-11.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
260.8%STRONG▾
ROA?
S&P
3
-89.6%WEAK▾
Cash Flow & Enterprise
FCF?$-131899000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day